(Based on Intent to Use) Diagnostic assays and test kits for use in laboratory, medical research and chemical research and development; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, enzymes, buffers proteins, antibodies, and molecular arrays of biological material for medical laboratory use

(Based on Intent to Use) Diagnostic assays and test kits for clinical use; Prognostic test kits for identifying disease risk factors and responses to therapeutic treatment; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, enzymes, buffers proteins, antibodies, and molecular arrays of biological material for clinical or medical use; prescription pharmaceutical preparations for use in diagnosing and treating human diseases and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, renal, metabolic or central nervous system diseases and weight disorders

(Based on Intent to Use) Optical disc media and other electronic media, namely, DVDs and CDs featuring genomic, proteomic and gene expression profile information for use in selecting therapeutics, evaluating efficacy and toxicity of treatments, evaluating treatment progression, prognosing disease or disease progression, and identifying disease heredity risk factors

Research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology and genomics, proteomics, diagnostics, pharmacogenomics, toxicogenomics and personalized medicine; computer services, namely, computer tracking of databases of life sciences information via computer networks in the field of personalized medicine

Diagnostic services, namely, diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, evaluation of clinical trial progress, and drug monitoring and monitoring of patient health progression; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors; computer services, namely, providing access to databases of life sciences information via computer networks in the field of personalized medicine, including phannacogenomic and toxicogenomic information